BrightSpring Health Services, Inc. Common Stock
BTSG · Price history
Price at last available close
$58.89
+$2.35 (+4.15%) 1M
2026-10-28
Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.
Company & revenue
About BrightSpring Health Services, Inc. Common Stock
Primary reporting period: 2025-12-31 · Research updated Oct 12, 2026. A research update is not a new financial filing.
Who they are
BrightSpring Health Services, Inc. operates across the United States, offering a range of healthcare solutions directly within patients' homes and local communities. The company's extensive platform focuses on providing crucial pharmacy and medical provider services, including both clinical care and supportive assistance, to individuals covered by Medicare, Medicaid, and private insurance. Patients receive care from a dedicated team of clinical professionals and licensed pharmacists.
How they make money
BrightSpring operates a home and community-based healthcare platform that generates revenue by providing pharmacy and provider services to complex, high-need patient populations. The company is primarily reimbursed through government programs such as Medicare and Medicaid, as well as commercial insurance plans, for delivering clinical and supportive care in lower-cost home and community settings.
Products & services
The company provides pharmacy services, home health care, primary care, rehabilitation, and behavioral health services for senior and specialty patient populations.
Brands & revenue mix
Pharmacy services subsidiary.
Separate brand revenue is not available in this research.Source
Revenue share is not unit sales or a best-seller ranking. Parent brands and included sub-brands can overlap; do not add overlapping rows.
Product / operating segments
No reconciled product or operating-segment revenue breakdown is available for the current research period. Company-wide revenue remains separate from segment disclosure.
Geographic revenue
No reconciled geographic revenue breakdown was confirmed for the current research period.
Customer types
Customer concentration
The company derives a significant portion of its revenue from government-funded programs, specifically Medicare and Medicaid, as disclosed in the 2025 annual report.
Suppliers, materials & equipment
- Pharmaceutical manufacturers and wholesalers — The company relies on various pharmaceutical manufacturers and wholesalers to supply the medications and clinical supplies necessary for its pharmacy operations.Source
Strengths
Sources
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
38
Poor
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
65
Fair
Financial Strength
68
Business Quality / Moat
90
Management
61
Growth Quality
53
Risk / Durability
15
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
47
Avoid
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
58/100
Building Historical Record
Model Score 58/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.
At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.
The model outlook is currently moderate.
- •Balance-sheet / debt profile scores strongly
- •Recent buyback activity is present
- •Debt service risk
- •Valuation is a weaker part of the current profile
- •Revenue fundamentals are weak
- •Asset quality is a weaker factor
Company-specific research
Questions worth answering for BTSG
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
- •Can BTSG maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
- •Is BTSG's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
- •Is BTSG's debt load manageable relative to cash generation, interest costs and upcoming maturities?
- •What future growth or profitability would be needed to justify BTSG's current valuation?
Essential Investment Snapshot
Wall Street Score
38
Opportunity Score
47
Market Cap
$11.67B
P/E Ratio
39.7
EPS
$1.43
52-Week High
$73.75
52-Week Low
$27.11
Beta
1.85
Intrinsic Value
$55.06
Analyst Target
$80.00
Shares Outstanding
219.8M
Total Revenue
$14.37B
Total Debt
$2.39B
Dividend
No current dividend
Liquidation Value / Share
$9.37
Momentum & Volatility Signals
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
Weakening momentum
Low movement
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for BTSG
Detected from reported data — verify before acting.Historical repurchase activity
Reported cash flows or share-count measures indicate past repurchase activity. This does not verify an active buyback authorization or future purchases.
Debt service risk
Interest coverage is low (~1.9x). Earnings may be strained to cover interest expense.
Community Sentiment
0 active · 0 total callsNo personal call yet on BTSG.
Potential upside factors
- +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
- +Integrated and scaled care delivery model.
- +Focus on high-need, high-cost patient populations.
- +Positive free cash flow may provide capacity to invest in growth.
Potential downside factors
- −Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Medical - Healthcare Information Services industry.
- −Dependence on government reimbursement rates and regulatory changes.
- −Operational risks associated with providing clinical care in home and community settings.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdownWas this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
Score Changes
5 historical score records availablePrevious Score
37
Sep 9, 2026
Change
+0.9
points
Current Score
38
Oct 1, 2026
Category Changes
BTSG increased 0.9 points because Valuation improved by 5.9 points.
Positive Contributors
- + Valuation improved by 5.9 points
Projected Score
Projected Score
43
Projected Change
+5.0 points
Preliminary comparable-period financial changes suggest improvement of approximately 5.0 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
Near Fair ValueCurrent Price
$58.99
Model Intrinsic Value
$55.06
Difference
+$3.93
+7.1% vs IV
Margin of Safety
-7.1%
Financial Charts
Revenue
Additional Metrics
Operating Cash Flow
Total Debt
Total Assets
Net Margin %
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
| Line Item | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14.37B | $12.91B | $11.27B | $8.83B | ···· | ···· | ···· | ···· | ···· |
| Cost of Revenue | $12.59B | $11.39B | $9.68B | $7.39B | ···· | ···· | ···· | ···· | ···· |
| Gross Profit | $1.78B | $1.52B | $1.59B | $1.43B | ···· | ···· | ···· | ···· | ···· |
| Research & Development | $0.00 | $0.00 | $0.00 | $0.00 | ···· | ···· | ···· | ···· | ···· |
| SG&A Expenses | $1.30B | $1.22B | $1.38B | $1.29B | ···· | ···· | ···· | ···· | ···· |
| Operating Expenses | $1.30B | $1.22B | $1.38B | $1.29B | ···· | ···· | ···· | ···· | ···· |
| EBITDA | $638.9M | $459.5M | $398.1M | $349.5M | ···· | ···· | ···· | ···· | ···· |
| Operating Income | $478.1M | $295.3M | $206.4M | $147.2M | ···· | ···· | ···· | ···· | ···· |
| Interest Expense | $152.3M | $157.3M | $228.4M | $324.6M | ···· | ···· | ···· | ···· | ···· |
| Income Before Tax | $295.5M | $137.9M | -$34.7M | -$177.4M | ···· | ···· | ···· | ···· | ···· |
| Income Tax Expense | $47.6M | $33.1M | -$14.2M | -$20.6M | ···· | ···· | ···· | ···· | ···· |
| Net Income | $294.0M | $190.7M | -$18.1M | -$154.6M | ···· | ···· | ···· | ···· | ···· |
| Basic EPS | $1.43 | $0.94 | $-0.09 | $-0.90 | ···· | ···· | ···· | ···· | ···· |
| Basic Shares | 206M | 203M | 193M | 171M | ···· | ···· | ···· | ···· | ···· |
| Diluted Shares | 220M | 220M | 193M | 171M | ···· | ···· | ···· | ···· | ···· |
Earnings Summary
Revenue
$3.87B
Estimate unavailable.
Revenue Beat/Miss
Not available (no estimate stored)
EPS
$0.39
Estimate unavailable.
EPS Beat/Miss
Not available (no estimate stored)
Debt Change
-12.0%
Cash Change
+685.5%
Margin Change
+1.3 pp
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Improved
- Margins expanded
- Cash position grew
- Debt reduced
Potential Score Impact
Positive indicators included revenue growth, EPS growth, cash levels, debt levels. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue increased 23.0%. EPS increased 200.0%. Cash increased 685.5%. Total debt declined 12.0%. Net income margin improved by 1.3 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Insider Activity
Guru / Smart Money
Guru Score
41
Smart Money
41
Number of Gurus
1
Total Guru Value
Avg Portfolio Weight
Largest Holder
Largest Holder %
New Positions
Increased Positions
Reduced Positions
Exited Positions
Net Guru Sentiment
Short Interest
Dividend History
Dividend data is not available yet. Missing data does not mean this company pays no dividend.
Conservative Projected Values
3 Years
$———.——
5 Years
$———.——
10 Years
$———.——
Conservative Projection Rate
——%
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Start 7-Day Free TrialHistorical Outperformance Record
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.
Start 7-Day Free TrialHistorical Trends
5 historical recordsHistorical Score Chart
3 of 5 records shownWall Street Score
Debt Score
Revenue Score
Asset Score
Capital Score
Management Score
Moat Score
Valuation Score
Buffett Score
Intrinsic Value
Value Reference
Margin of Safety %
Related Companies
Medical - Healthcare Information ServicesNews
BrightSpring: Margins Keep Improving While Expanding Its Pharmacy Footprint
BrightSpring Health Services, Inc. to Announce Third Quarter 2026 Financial Results on October 30, 2026
BTSG Deploys AI Across Operations: Will It Improve Margins?
BrightSpring Health Services, Inc. (BTSG) is a Top-Ranked Value Stock: Should You Buy?
Rumor Mill · BTSG
Corporate developments & opportunities
No reviewed developments match this filter.
Evidence credibility is not a forecast of stock performance. Rumor Mill is separate from the WSS score.
Related Stock Research
Continue researching this company with related Wall Street Score rankings and investing guides.
Score Alerts
Premium unlocks alerts when a score rises, falls, or reaches your target price.
Start 7-Day Free TrialPortfolio Score
Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.
Start 7-Day Free Trial